Niacinamide may be Associated with Improved Outcomes in COVID-19-Related Acute Kidney Injury: An Observational Study
2020
Background: Acute kidney injury (AKI) is a significant complication of Coronavirus Disease 2019 (COVID-19), with no effective therapy. Niacinamide, a vitamin B3 analog, has some evidence of efficacy in non-COVID-19-related AKI. The objective of this study is to evaluate the association between niacinamide therapy and outcomes in patients with COVID-19-related AKI. Methods: We implemented a quasi-experimental design with non-random, prospective allocation of niacinamide in 201 hospitalized adult patients, excluding those with baseline estimated glomerular filtration rate
Keywords:
-
Correction
-
Source
-
Cite
-
Save
20
References
2
Citations
NaN
KQI